Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1007/s11136-013-0597-0) contains supplementary material, which is available to authorized users.
Rheumatoid arthritis (RA) is associated with extra-articular features (ExRA) and other co-morbidities. The aim of this study is to quantify their relative contribution to quality of life (QOL) in patients with RA.
A consecutive series of 114 ambulatory RA patients aged between 40 and 65 years were assessed by a research nurse on a single occasion. Assessment included a patient questionnaire (including EQ-5D), medication review and fasting venous blood sample. Medical records were reviewed by a rheumatologist for co-existing conditions. Multiple linear regression was used to adjust mean differences in EQ-5D in the presence/absence of co-existing conditions for age, sex, university education, arthritis duration, rheumatoid factor, erythrocyte sedimentation rate, current disease-modifying drug therapy, previous hand joint erosions and joint surgery.
Mean age was 54 years (82 % female) and median arthritis duration 10 years. Unadjusted EQ-5D was −0.09 (95 % CI −0.18 to −0.01) lower in patients with any co-existing condition. EQ-5D scores were inversely correlated with the overall number of co-existing conditions (Spearman’s ρ −0.31, p = 0.001), number of co-morbidities (ρ −0.22, p = 0.02) and number of ExRA features (ρ −0.22, p = 0.02). There was a linear trend of lower EQ-5D with increasing number of co-existing conditions (p = 0.003). EQ-5D was −0.18 (95 % CI −0.33 to −0.02) lower in the presence of more than two co-existing conditions compared to none. Co-morbidity and ExRA features were associated with comparable adjusted reductions (−0.05 vs. −0.06) in EQ-5D scores.
A wide range of co-existing conditions are associated with poorer QOL in patients with RA.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Supplementary material 1 (PDF 303 kb)11136_2013_597_MOESM1_ESM.pdf
Huntley, A. L., Johnson, R., Purdy, S., Valderas, J. M., & Salisbury, C. (2012). Measures of multimorbidity and morbidity burden for use in primary care and community settings: A systematic review and guide. The Annals of Family Medicine,10, 134–141. CrossRef
Diederichs, C., Berger, K., & Bartels, D. B. (2011). The measurement of multiple chronic diseases—a systematic review on existing multimorbidity indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences,66, 301–311. CrossRef
Turesson, C., O’Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2002). Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. The Journal of Rheumatology,29, 62–67. PubMed
Avina-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008). Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research,59, 1690–1697. CrossRef
Eser, F., Garip, Y., & Bodur, H. (2012). Extraarticular manifestations in Turkish patients with rheumatoid arthritis, impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International,32, 1521–1525. PubMedCrossRef
Salaffi, F., Carotti, M., Ciapetti, A., Gasparini, S., & Grassi, W. (2011). A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology,29, 661–671. PubMed
Rupp, I., Boshuizen, H. C., Jacobi, C. E., Dinant, H. J., & van den Bos, G. (2004). Comorbidity in patients with rheumatoid arthritis: Effect on health-related quality of life. The Journal of Rheumatology,31, 58–65. PubMed
Crilly, M. A., Kumar, V., Clark, H. J., Scott, N. W., Macdonald, A. G., & Williams, D. J. (2009). Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: A dose-response relationship independent of established cardiovascular risk factors. Rheumatology,48, 1606–1612. PubMedCrossRef
The EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy,16, 199–208. CrossRef
Dolan, P., Gudex, C., Kind, P., & Williams, A. (1995). A social tariff for EuroQol, results from a UK general population survey. Centre For Health Economics. York: University of York. (Discussion Paper 138).
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology,36, 551–559. CrossRef
Harrison, M. J., Davies, L. M., Bansback, N. J., Ingram, M., Anis, A. H., & Symmons, D. P. (2008). The validity and responsiveness of generic utility measures in rheumatoid arthritis: A review. The Journal of Rheumatology,35, 592–602. PubMed
Linde, L., Sorensen, J., Ostergaard, M., Horslev-Petersen, K., & Hetland, M. L. (2008). Health-related quality of life, validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. The Journal of Rheumatology,35, 1528–1537. PubMed
Atroshi, I., Gummesson, C., McCabe, S. J., & Ornstein, E. (2007). The SF-6D health utility index in carpal tunnel syndrome. Journal of Hand Surgery European,32, 198–202. CrossRef
Turesson, C., McClelland, R. L., Christianson, T., & Matteson, E. (2008). Clustering of extraarticular manifestations in patients with rheumatoid arthritis. The Journal of Rheumatology,35, 179–180. PubMed
Young, A., & Koduri, G. (2007). Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology,21, 907–927. CrossRef
Palm, O., Garen, T., Enger, T. B., et al. (2008). Clinical pulmonary involvement in primary Sjogren’s syndrome: Prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology,52, 173–179. CrossRef
- Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis
Michael A. Crilly
Marjorie C. Johnston
- Springer International Publishing